CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Randomized Study of Adjuvant Immunotherapy With Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for State II (Modified Astler-Coller B2) Adenocarcinoma of the Colon

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00002968
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:44.232636+00:00
Published At: 2025-12-29T00:00:00+00:00
Record Updated At: 2025-12-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mucinous Adenocarcinoma of the Colon", "Signet Ring Adenocarcinoma of the Colon", "Stage IIA Colon Cancer", "Stage IIB Colon Cancer", "Stage IIC Colon Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-29"
protocolSection.identificationModule.nctId: "NCT00002968"
protocolSection.identificationModule.officialTitle: "Phase III Randomized Study of Adjuvant Immunotherapy With Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for State II (Modified Astler-Coller B2) Adenocarcinoma of the Colon"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.